Marshwinds Advisory’s AbbVie ABBV Stock Holding History

Marshwinds Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$2.8M	Sell	30,341 -1,672	-5%	-$147K	1.5%	23
2018 Q3	$3.03M	Sell	32,013 -198	-0.6%	-$18.8K	1.38%	26
2018 Q2	$2.98M	Buy	32,211 +1	+0%	+$98	1.41%	26
2018 Q1	$3.05M	Sell	32,210 -148	-0.5%	-$16.3K	1.45%	26
2017 Q4	$3.13M	Sell	32,358 -1,299	-4%	-$122K	1.45%	26
2017 Q3	$2.99M	Sell	33,657 -198	-0.6%	-$15.1K	1.39%	27
2017 Q2	$2.46M	Buy	33,855 +279	+0.8%	+$18.8K	1.16%	35
2017 Q1	$2.19M	Buy	33,576 +5,852	+21%	+$368K	1.02%	38
2016 Q4	$1.74M	Buy	27,724 +1,460	+6%	+$89.1K	0.83%	43
2016 Q3	$1.66M	Buy	26,264 +178	+0.7%	+$11.5K	0.81%	45
2016 Q2	$1.61M	Buy	26,086 +750	+3%	+$45.7K	0.79%	43
2016 Q1	$1.45M	Sell	25,336 -100	-0.4%	-$5.57K	0.74%	44
2015 Q4	$1.51M	Hold	25,436	–	–	0.79%	42
2015 Q3	$1.38M	Sell	25,436 -500	-2%	-$32.5K	0.74%	43
2015 Q2	$1.74M	Sell	25,936 -250	-1%	-$16.3K	0.88%	39
2015 Q1	$1.53M	Hold	26,186	–	–	0.73%	45
2014 Q4	$1.71M	Hold	26,186	–	–	0.81%	40
2014 Q3	$1.51M	Hold	26,186	–	–	0.75%	40
2014 Q2	$1.48M	Hold	26,186	–	–	0.71%	46
2014 Q1	$1.35M	Sell	26,186 -125	-0.5%	-$6.32K	0.68%	50
2013 Q4	$1.39M	Buy	26,311 +250	+1%	+$12.3K	0.73%	45
2013 Q3	$1.17M	Buy	26,061 +375	+1%	+$16.6K	0.67%	52
2013 Q2	$1.06M	Buy	+25,686	New	+$1.12M	0.63%	54

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marshwinds Advisory's ABBV Position: Q4 2018 in Review

Marshwinds Advisory reduced its AbbVie (ABBV) stake by 5.2% in Q4 2018, selling an estimated $147K and leaving 30,341 shares worth $2.8M. The position accounts for 1.5% of the portfolio, ranked #23.

Marshwinds Advisory first reported a position in ABBV in Q2 2013 and has held it in 23 quarters since. The position peaked at $3.13M in Q4 2017. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

Marshwinds Advisory held 30,341 shares of AbbVie worth $2.8M as of Q4 2018.
Marshwinds Advisory sold 1,672 AbbVie shares in Q4 2018, an estimated $147K.
AbbVie made up 1.5% of Marshwinds Advisory's portfolio in Q4 2018, its #23 holding.
Marshwinds Advisory first reported a position in AbbVie in Q2 2013 and has held it in 23 quarters since.
Marshwinds Advisory's AbbVie position peaked at $3.13M in Q4 2017.
2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Marshwinds Advisory's 13F filing for Q4 2018, filed 7 Jan 2019.